8th EACTS Mechanical Circulatory Support Summit

Event Information

Date/Duration

7 – 9 November 2024
Location

Prague, Czech Republic
See HERE for more information
Chairmen

I Netuka, Prague; G Färber, Homburg Saar; J Gummert, Bad Oeynhausen; V Falk, Berlin; D Zimpfer, Vienna; F Gustafsson, Copenhagen
Summit Format

In-person meeting
Interactive lectures
Live-in-a-box cases
Keynote presentations
Summit Fee

Members: €610
Non-Members: €710
Residents: €390
Target Audience

Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and VAD coordinators, medical industry (cardiac device including ECMO development and production). Pediatric cardiologists and congenital heart disease surgeons.
Abstract Poster Submission

Abstract poster submissions are now OPEN!
Closing date: Sunday 29 September
Please click HERE for more information.
8th MCS Rising Stars Quiz

We are happy to announce that for the first time, delegates are invited to submit a team to participate in the MCS annual quiz.
Members of the team should be from the same country or the same institution and may have a maximum of 4 participants.
Spaces are limited, and we may not be able to accommodate all that apply, so please register your interest by emailing [email protected] and we will get back to you.

EACTS Academy terms and conditions.

The 8th EACTS Mechanical Circulatory Support Summit will be an in-person meeting and run from 7-9 November 2024 in Prague, Czech Republic

08:00	Introduction
	Welcome address from the Czech Society of Cardiology and the Czech Cardiovascular Surgical Society
08:15	Session 1: Advanced HF: Gaps in therapy and communication
	Residual risks beyond drugs and pacemakers in advanced HF – 30.000 feet perspective
	Timely recognition and referral of advanced HF
	Who needs more than interventional procedures and CIED in advanced HF – a continuum of care
	Growing acute and chronic heart failure networks of excellence – one approach fits all?
	How should we communicate risks and benefits of LVAD therapy?
	Panel discussion
10:00	Break
10:30	Session 2: Have we advanced outcomes in cardiogenic shock?
	Phenotyping to a therapeutic success in cardiogenic shock
	Debate:
	– PRO: Danger ahead! All patients with MI-CS should be supported with a mAFP
	– CON: Danger ahead! All patients with MI-CS should be supported with a mAFP
	New microaxial flow devices – more diversity on a horizont?
	ECLS in CS – quo vadis?
	Combination is a right solution – shaken, not stirred…!
	Panel discussion
12:00	Lunch
13:00	Session 3: The paradigm of myocardial recovery with MCS
	Bridging to recovery in high-risk cardiac surgery – expanding the opportunity
	Implications of partial recovery with LVADs – is there still a role for medical therapy?
	Weaning-off from durable LVAD. Who, when? Lessons learned from VAD wean registry
	Deactivation of LVAD support for myocardial recovery – surgical perspectives
	Panel discussion
14:20	Break
14:50	Session 4: Novel concepts in durable LVADs
	Preconditioning for better outcomes with durable LVAD: A key to success!
	The Paradox of non-surgical bleeding in durable VADs
	Anticoagulation strategies in continuous flow LVADs – VKA or DOAC
	Getting closer to smart pumping with LVADs – the future is now?
	An ideal LVAD driveline – Different or none?
	Panel discussion
16:00	Session 5: Successful LVAD bridge to transplantation
	LVADs and allosensitization – challenges, solutions and opportunities
	Debate: Optimal donor organ procurement strategies in LVAD patients
	– Normothermic oxygenated perfusion for LVAD transplants – only the best is good enough!
	– Hypothermic oxygenated and non-oxygenated procurement strategies – do not over do!
	Vasoplegia and PGD after HTx with MCS bridge
	Panel discussion
17:30	Moderated poster session & welcome reception
19:30	Close

08:00	Session 6: Data and guidelines in MCS – forging new directions
	Transatlantic guidelines in tMCS: An update
	Euromacs and durable MCS guidelines: Pearls of wisdom
	Artificial intelligence and durable MCS
	If I were to create an ideal registry in MCS, it would be…
	Panel discussion
09:15	Session 7: Improving outcomes in ambulatory LVADs
	Optimizing patient and LVAD interaction – diagnostic sensors and therapeutic clips
	Aortic interventions in LVADs: At implant or later?
	Outflow graft complications: Prevention, early recognition and repair
	Surgical management of driveline infection
	Panel discussion
10:30	Break
11:00	Session 8: Manage the patient, not the pump only!
	Assessing QOL in LVAD recipients
	Patient education: Before and after implant
	Caregiver burden and support
	Telemedicine in ambulatory MCS population
	Panel discussion
12:00	8th MCS Rising Stars Quiz
13:00	Lunch
14:00	Session 9: Ongoing pivotal trials and designs in MCS
	Learning from the ARIES pivotal trial: Novel insights
	TEC – LVAD Trial
	Rapid fire updates on ongoing trials: Fully magnetically levitated LVAD I
	Rapid fire updates on ongoing trials: Fully magnetically levitated LVAD II
	Rapid fire updates on ongoing trials: Fully implantable intraventricular LVAD
	Rapid fire updates on ongoing trials: Unload HF-CS
	Panel discussion
15:15	Session 10: What’s new in the pipeline
	Industry updates
16:15	Break
16:45	Session 11: When supporting one ventricle is not enough
	Deeper understanding of RHF in MCS
	Are we any closer in risk stratification with LVADs?
	Surgical options for durable biventricular support
	Xenotransplantation and biomechanical heart: The future of a BioBIVAD?
	Panel discussion
18:00	Close

08:00	Session 12:Complex cases and creative solutions
	Vienna
	Izmir
	Torino
	Riyadh
	Bad Oyenhausen
	Warsaw
	Prague
	Manchester
	Panel discussion
09:15	Session 13: Paediatric MCS
	MCS in the neonate – best solutions and outcomes
	How small is small for durable LVAD bridging in peds? Clear cut-off or fluid target?
	Peds and MCS: Stunned field or innovative arena?
	Panel discussion
10:15	Break
	Session 14: Video sessions: How I do it…
	Berlin
	Wroclaw
	Tel Aviv
	Zagreb
	Budapest
	Panel discussion
11:50	Closing Remarks
18:00	Close

8th EACTS Mechanical Circulatory Support Summit

Event Information

Summit programme

Thursday 7 November

Friday 8 November

Saturday 9 November

Chairmen

Ivan Netuka

Gloria Färber

Jan Gummert

Volkmar Falk

Daniel Zimpfer

Finn Gustafsson